Sivik Global Healthcare LLC Has $5.46 Million Position in Cigna Group $CI

Key Points

• Sivik Global Healthcare LLC increased its position in Cigna Group by 32.0%, now owning 16,500 shares valued at approximately $5.46 million, making it the 18th largest holding in their portfolio.
• Cigna Group reported earnings of $7.20 per share for the last quarter, exceeding analysts' expectations of $7.15, and its revenue increased by 11.0% year-over-year to $67.13 billion.
• The company recently declared a quarterly dividend of $1.51 per share, representing an annualized dividend yield of 2.0% and a payout ratio of 32.97%.

Sivik Global Healthcare LLC grew its position in Cigna Group (NYSE:CI - Free Report) by 32.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,500 shares of the health services provider's stock after buying an additional 4,000 shares during the quarter. Cigna Group accounts for about 1.5% of Sivik Global Healthcare LLC's portfolio, making the stock its 18th largest holding. Sivik Global Healthcare LLC's holdings in Cigna Group were worth $5,455,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Family Legacy Inc. raised its position in shares of Cigna Group by 0.5% in the 1st quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider's stock valued at $2,138,000 after buying an additional 31 shares in the last quarter. Impact Investors Inc increased its position in Cigna Group by 1.6% during the 1st quarter. Impact Investors Inc now owns 1,975 shares of the health services provider's stock worth $650,000 after purchasing an additional 31 shares in the last quarter. Mission Wealth Management LP increased its position in Cigna Group by 1.5% during the 1st quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider's stock worth $691,000 after purchasing an additional 32 shares in the last quarter. Westend Capital Management LLC increased its position in Cigna Group by 8.1% during the 1st quarter. Westend Capital Management LLC now owns 427 shares of the health services provider's stock worth $140,000 after purchasing an additional 32 shares in the last quarter. Finally, Financial Network Wealth Advisors LLC increased its position in Cigna Group by 26.8% during the 1st quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider's stock worth $53,000 after purchasing an additional 34 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Trading Down 1.7%

CI opened at $301.00 on Friday. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $358.88. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market capitalization of $80.35 billion, a price-to-earnings ratio of 16.43, a PEG ratio of 0.88 and a beta of 0.45. The company's 50 day moving average price is $294.68 and its two-hundred day moving average price is $309.23.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same period in the previous year, the firm posted $6.72 EPS. The company's revenue for the quarter was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group's dividend payout ratio is currently 32.97%.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 28,526 shares of the company's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company's stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the company's stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

CI has been the subject of a number of research analyst reports. Barclays upped their price objective on shares of Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Cantor Fitzgerald reiterated an "overweight" rating and set a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a research report on Monday, June 23rd. Guggenheim reiterated a "buy" rating and set a $350.00 price objective (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Finally, Truist Financial set a $375.00 price objective on shares of Cigna Group in a research report on Tuesday, September 2nd. Two research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $372.69.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.